SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is experiencing significant volatility as investors weigh the stock's robust fundamentals and long-term AI memory demand against broader market sentiment driven by rising Middle East tensions and concerns over algorithmic efficiency breakthroughs like Google's TurboQuant. While the community remains deeply divided, with many bulls viewing the recent slide as a structural discount for a long-term winner, traders are actively debating whether current support levels will hold or if the stock faces further downside pressure from sector-wide technical decay.

Applied Digital Corporation

Applied Digital is experiencing intense volatility as investors weigh the company's long-term potential in AI infrastructure against a macro-driven sell-off fueled by geopolitical uncertainty and broader debt concerns. The community remains deeply divided, with many participants panic-selling while others aggressively advocate for buying the dip, pinning their hopes on upcoming earnings and anticipated hyperscaler lease announcements as critical catalysts to stop the bleeding.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

XRP is currently trending as investors debate the impact of the pending Clarity Act on long-term institutional adoption and the asset's regulatory status in the U.S. Community sentiment is deeply polarized, with many users actively discussing the contrast between Ripple's infrastructure development and the coin's recent price stagnation.

iShares Trust - iShares Russell 2000 ETF

iShares Russell 2000 ETF

The Russell 2000 is experiencing heightened volatility as market participants weigh geopolitical developments in the Middle East against shifting expectations for interest rate policy. Community sentiment remains deeply divided, with many traders closely monitoring institutional order flow and the reliability of official diplomatic updates for signs of a potential market bottom.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology is trending as investors debate the potential of new large-scale AI infrastructure deals against persistent concerns over stock dilution, complex governance structures, and historical volatility. While some community members point to significant insider ownership and a massive contract pipeline as evidence of a long-term turnaround, skeptics remain focused on the company's past failure to meet previous projections and ongoing transparency issues.

Federal National Mortgage Association is a government-sponsored company, which engages in the provision of liquidity for purchases of homes and financing of multifamily rental housing and refinancing existing mortgages. It operates through the Single-Family and Multifamily segments. The Single-Family segment offers liquidity to the mortgage market and increases the availability and affordability of housing for single families. The Multifamily segment includes guaranty fees on mortgages and on multifamily mortgage loans. The company was founded in 1938 and is headquartered in Washington, DC.

Federal National Mortgage Association

FNMA is seeing high trading volatility as investors react to speculative news and influential comments from prominent hedge fund managers regarding the company's potential exit from government control. The community remains deeply divided, with many actively debating the long-term viability of the stock versus the risk of participating in what some critics describe as a headline-driven pump-and-dump scheme.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is experiencing intense volatility and downward pressure as investors react to concerns over AI memory demand following reports of new efficiency algorithms and broader semiconductor sector weakness. While some community members fear a prolonged cyclical correction or governance risks, others view the sharp pullback as a tactical buying opportunity, citing strong underlying fundamentals and the persistent need for high-performance memory.

Stellantis NV engages in the designing, engineering, manufacturing, distributing, and selling of vehicles and components. It offers its products under the Abarth, Alfa Romeo, Chrysler, Citroën, Dodge, DS Automobiles, Fiat, Jeep, Lancia, Maserati, Opel, Peugeot, Ram Trucks, Vauxhall, Free2move, and Leasys brands. The company was founded on April 1, 2014 and is headquartered in Hoofddorp, the Netherlands.

Stellantis N.V

Stellantis is currently facing significant market pressure following a massive $26 billion restructuring charge and the suspension of its dividend, driving concerns about the company's long-term profitability and execution risks. Despite the sell-off, the community is actively debating the stock's potential for a cyclical turnaround, fueled by recent product pivots back toward traditional internal combustion models and a renewed focus on core brands like Jeep and Ram.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is facing significant downward pressure as investors weigh geopolitical risks in the Middle East and a series of high-level management departures within its autonomous driving division. Community sentiment remains deeply polarized, with many traders debating whether the current price action signals a long-term bottoming process or a precarious bull trap fueled by unsustainable valuation multiples.

Invesco QQQ Trust Series 1 - Units of beneficial interest

The QQQ is experiencing heightened volatility driven by conflicting headlines regarding the potential end of the Iran conflict and the status of the Strait of Hormuz, causing rapid fluctuations in sentiment. Market participants are actively debating whether these geopolitical developments represent a genuine diplomatic breakthrough or a tactical distraction, with many cautious about the ongoing impact of energy supply concerns on broader tech sector performance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH), a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs, announced today it...

<ul class="summary-bullets"><li>Michael Hearne has been appointed Chief Financial Officer, replacing Joe Miller.</li><li>Decision to remove Greenleaf and install Tang as CEO represents a “complete validation” of concerns raised for nearly three years, major shareholder MKT Capital said in a statement.</li><li>The company is looking to initiate a clinical study of Aritinercept for an autoimmune disease in the first half of 2026.&nbsp;</li></ul>Aurinia Pharmaceuticals (AUPH) drew strong retail interest on Monday after naming Kevin Tang as Chief Executive Officer, fueling investor hopes of a “new positive era” for the company.<a href="https://stocktwits.com/symbol/AUPH">AUPH stock</a> was up more than 6% at the time of writing.Tang, who is also the Chair of the Board, will replace Peter Greenleaf, who has been the company’s CEO for the past 7 years. Tang, an industry veteran, previously served as Chairman of La Jolla Pharmaceutical Company from 2014 through its acquisition by Innoviva in 2022.In 2013, Tang founded Odonate Therapeutics and served as its Chairman and CEO through 2022. Mr. Tang also co-founded Ardea Biosciences in 2006 and Heron Therapeutics in 2009. From 2009 through its acquisition by Keenova Therapeutics in 2010, Tang served as Director of Penwest Pharmaceuticals Co.Among other changes, Michael Hearne has been appointed Chief Financial Officer, replacing Joe Miller. Meanwhile, Ryan Cole was appointed as Chief Operating Officer, and Thomas Wei took over as Chief Scientific Officer.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment flipped to ‘bullish’ from ‘bearish,’ amid ‘high’ message volumes.<img src="https://news.stocktwits-cdn.com/AUPH_jpg_4ef07ce8ea.webp" alt="AUPH.jpg">One user speculated on the implications of the management change for the company, akin to the potential for it to go private.<stembedurl>https://stocktwits.com/US_Bull/message/648264487</stembedurl>Another user said, “Hopefully this starts the beginning of a new positive era”.<stembedurl>https://stocktwits.com/cjohoya/message/648275231</stembedurl>In 2021, Aurinia Pharmaceuticals launched LUPKYNIS, an FDA-approved oral treatment for adults with active Lupus Nephritis. The company also plans to begin a clinical study of Aritinercept for an autoimmune disease in the first half of 2026. Aurinia reported its first full-year profit in December 2024.<h2 class="st-heading-2">MKT’s Statement On Management Changes</h2>MKT Capital, a major long-term shareholder of Aurinia, issued a statement following the appointment of Kevin Tang as CEO.“Today marks a watershed moment for Aurinia shareholders. Since 2019, we have tirelessly advocated for accountability, disciplined capital allocation, and genuine alignment between management and the true owners of this Company – its shareholders. The Board’s decision to remove CEO Peter Greenleaf and his executive team, and to install Chair Kevin Tang as CEO, represents a complete validation of the concerns we have raised for nearly three years,” said Antoine Khalife, Founder of MKT Capital.In April 2025, MKT Capital announced its intention to withhold support for Greenleaf at the 2025 Annual General Meeting.Year-to-date, the stock has fallen 6.5%.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/nvda-stock-200-dma-rebound-ai-factories-deal/cZ3mgN2RI0Z">NVDA Stock Rebounds But Remains Below Key Support For Second Session: Retail Sees Massive Upside</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Aurinia Pharmaceuticals logo is seen displayed on a smartphone screen

AUPH Stock Rallies After CEO Shake-Up: Retail Bulls Bet On Turnaround

Aurinia Pharmaceuticals named Kevin Tang as its Chief Executive Officer, replacing Peter Greenleaf.

Equity

Why Aurinia Pharmaceuticals Stock Is Surging Monday Morning

Aurinia Pharmaceuticals shares are trading higher Monday after announcing a leadership transition seen as a sign of continuity and strategy.read more...

Aurinia Announces Management Transition

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) announced today that Kevin Tang, Aurinias Chair of the Board, will succeed Peter Greenleaf as Chief Executive Officer. Peter will continue as a consultant...

Aurinia Pharmaceuticals (NASDAQ:AUPH) Stock Passes Below 200-Day Moving Average - Here's What Happened

Aurinia Pharmaceuticals (NASDAQ:AUPH) Stock Crosses Below 200-Day Moving Average - Time to Sell...

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Receives Average Recommendation of "Hold" from Analysts

Shares of Aurinia Pharmaceuticals Inc (NASDAQ:AUPH - Get Free Report) (TSE:AUP) have been assigned a consensus rating of "Hold" from the six analysts that are currently covering the company...

Aurinia Pharmaceuticals (NASDAQ:AUPH) Stock Passes Below 50-Day Moving Average - Should You Sell?

Aurinia Pharmaceuticals (NASDAQ:AUPH) Stock Crosses Below 50 Day Moving Average - Here's What Happened...

Aurinia Pharmaceuticals (NASDAQ:AUPH) Director Buys $7,224,981.61 in Stock

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH - Get Free Report) (TSE:AUP) Director Kevin Tang purchased 516,439 shares of Aurinia Pharmaceuticals stock in a transaction dated Friday, February 27th. The...

GSA Capital Partners LLP Trims Stake in Aurinia Pharmaceuticals Inc $AUPH

GSA Capital Partners LLP trimmed its position in Aurinia Pharmaceuticals Inc (NASDAQ:AUPH - Free Report) (TSE:AUP) by 95.9% in the 3rd quarter, according to its most recent 13F filing with the...

Aurinia Pharmaceuticals (NASDAQ:AUPH) Posts Earnings Results

Aurinia Pharmaceuticals (NASDAQ:AUPH - Get Free Report) (TSE:AUP) issued its quarterly earnings results on Thursday. The biotechnology company reported $1.53 earnings per share (EPS) for the quarter...

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Patrick OShaughnessy - @patrick_oshag on X

Citrini - @Citrini7 on X

Bucco Capital - @buccocapital on X

Joe Weisenthal - @TheStalwart on X

The must-watch individual or show that brings entertainment to finance. This award celebrates the content you look forward to daily - bringing a sharp market edge to engaging discussions. 

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	$0.19	--	--	N/A
Q4 '25	$0.22	$1.53	606.15%	BEAT
Q3 '25	$0.16	$0.23	43.75%	BEAT
Q2 '25	$0.15	$0.16	9.09%	BEAT
Q1 '25	$0.10	$0.16	60.00%	BEAT

AUPH
Aurinia Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest AUPH News

AUPHAurinia Pharmaceuticals Inc